A novel compression-coated doughnut-shaped tablet design for zero-order sustained release.

Eur J Pharm Sci

Department of Pharmacy and Pharmacology, University of the Witwatersrand, 7 York Rd, Parktown, 2193 Johannesburg, South Africa.

Published: August 2004

A novel coated doughnut-shaped tablet is evaluated as to its ability to be manufactured in a reproducible manner, and as to whether it releases model drugs at a zero-order rate. The doughnut-shaped tablets were compressed using specially designed punches, which make automated production feasible. In the preliminary part of the experiment, HPMC K15M mixed with gelatin was found to be the most suitable coating tablet material with respect to its disintegration and adherence properties. The adherence of the coating tablet to ibuprofen cores was not optimal, so different concentrations of gelatin, to act as a plasticiser and enhance adherence, were further investigated. Friability results of the coated doughnut-shaped tablet indicate that coating tablets containing 20% and 30% gelatin had a percentage weight losses of less than 1% after 100 revolutions in a Roche friabilator. For all the concentrations of gelatin, the granule blends had angle of repose values in the range of 22.01-17.8 degrees. The compressibility factor, as measured from the slopes of the natural logarithm of compressional force versus crushing strength, were 121.91 +/- 2.36, 132.64 +/- 3.60, and 88.54 +/- 11.52 for the coating tablet granules containing 10%, 20%, and 30% gelatin in HPMC K15M, respectively. The composition of the coating tablet did not affect the rate of release of both caffeine and ibuprofen from the coated doughnut-shaped tablets. The coatings also adhered to the core tablets for the entire duration of the release of the drugs.

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ejps.2004.05.004DOI Listing

Publication Analysis

Top Keywords

coating tablet
16
doughnut-shaped tablet
12
coated doughnut-shaped
12
doughnut-shaped tablets
8
hpmc k15m
8
concentrations gelatin
8
20% 30%
8
30% gelatin
8
tablet
7
doughnut-shaped
5

Similar Publications

Formulation development and scale-up of dutasteride liquisolid tablets.

Drug Dev Ind Pharm

January 2025

Department of Pharmaceutical Technology and Biopharmaceutics, Faculty of Pharmacy, Jagiellonian University Medical College, ul. Medyczna 9, 30-688 Krakow, Poland.

Introduction: Liquisolid (LS) technology is particularly advantageous for poorly water-soluble drugs administered in very low doses because of the improved dissolution rate and superior content uniformity. However, there is a lack of research papers describing the application of this concept on an industrial scale. Thus, we present trials conducted to develop tablets containing 0.

View Article and Find Full Text PDF

Deep learning-based defect detection in film-coated tablets using a convolutional neural network.

Int J Pharm

January 2025

Process Research & Development, Merck & Co., Inc., Rahway, NJ, USA.

Film-coating is a critical step in pharmaceutical manufacturing. Traditional visual inspections for film-coated tablet defect assessment are subjective, inefficient, and labor-intensive. We propose a novel approach utilizing machine learning and image analysis to address these limitations.

View Article and Find Full Text PDF

Methotrexate (MTX) is classified as an antimetabolite. It's commonly used to treat lung cancer. MTX is an immunosuppressant following the above-mentioned mechanism of action due to its poor selectivity.

View Article and Find Full Text PDF

Orodispersible film (ODF) is one of the novel formulations that disintegrate rapidly in the mouth without the requisite for water compared to other conventional oral solid dosage formulations. This delivery system serves as a convenient mode of administration, especially in patients who have dysphagia and fluid restriction, being beneficial to pediatric, geriatric, and bedridden patients. A novel sildenafil ODF containing sildenafil citrate is formulated to be used in patients with erectile dysfunction (ED).

View Article and Find Full Text PDF

In Vivo Animal Spices and Experimental Technique to Evaluate Sustained Release Granules.

Biopharm Drug Dispos

January 2025

Bioavailability Research Project, Formulation Research Institute, Otsuka Pharmaceutical Co. Ltd., Tokushima, Japan.

Establishment of a suitable animal model to evaluate sustained release (SR) formulations is very important because it reduces the development time of SR formulations. Beagle dogs are often used to evaluate prototype formulations since they can be directly administered powder, such as drug substance. However, the physiological condition of dogs is very different to that of humans.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!